Eragon AI vs a2z Radiology AI

Side-by-side comparison of AI visibility scores, market position, and capabilities

Eragon AI

EmergingArtificial Intelligence

Prompt-Native Enterprise Software

Raised $12M seed at $100M valuation (Mar 2026) led by Long Journey Ventures and Soma Capital. Replaces traditional enterprise SaaS UX (Salesforce, Jira, Tableau) with prompt interface. On-prem model weights.

About

Eragon AI is building a prompt-native enterprise operating system — replacing the button-clicking UX of traditional enterprise software (Salesforce, Jira, Tableau) with a natural language interface where users describe their intent and AI agents handle the workflow. The company raised $12 million in seed financing at a $100 million valuation in March 2026, led by Long Journey Ventures and Soma Capital. Eragon integrates with Salesforce, Snowflake, Tableau, and Jira while running AI inference on customer-hosted model weights, addressing enterprise data sovereignty requirements.

Full profile

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.